Ultrasound Joint Inflammation in Rheumatoid Arthritis in Clinical Remission: How Many and Which Joints Should Be Assessed?

Arthritis Care and Research

Volumn 65, Issue 4, 2013, Pages 512-517

  Naredo, Esperanza ^a   Valor, Lara ^a   De La Torre, Inmaculada ^a   Martínez Barrio, Julia ^a   Hinojosa, Michelle ^a   Aramburu, Francisco ^a   Ovalles Bonilla, Juan Gabriel ^a   Hernández, Diana ^a   Montoro, María ^a   González, Carlos Manuel ^a   Lõpez Longo, Javier ^a   Monteagudo, Indalecio ^a   Carreño, Luis ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; ANKLE; ARTHRITIS; ARTICLE; CLINICAL ASSESSMENT; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; REMISSION; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SINGLE BLIND PROCEDURE; SYNOVITIS; WRIST;

ADULT; AGED; AGED, 80 AND OVER; ANKLE JOINT; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY; MALE; METATARSOPHALANGEAL JOINT; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE;

EID: 84875717993     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21869     Document Type: Article

References (31)

1. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69: 631-7.
2. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69: 964-75.
3. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011; 63: 573-86.
4. Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A, et al. Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 2002; 61: 895-904.
5. Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004; 63: 382-5.
6. Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A,. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey-scale and power Doppler ultrasonography. Ann Rheum Dis 2005; 64: 375-81.
7. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F,. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2001; 44: 331-8.
8. Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T, Ostergaard M,. Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum 2001; 44: 2018-23.
9. Terslev L, Torp-Pedersen S, Savnik A, von der Recke O, Qvistgaard E, Danneskiold-Samsoe B, et al. Doppler ultrasound and magnetic resonance imaging of synovial inflammation of the hand in rheumatoid arthritis: a comparative study. Arthritis Rheum 2003; 48: 2434-41.
10. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54: 3761-73.
11. Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P,. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Rheum 2007; 57: 1564-7.
12. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2958-67.
13. Scire CA, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R,. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford) 2009; 48: 1092-7.
14. Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Karim Z, et al. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: a clinical and imaging comparative study. Arthritis Rheum 2009; 60: 1915-22.
15. Balsa A, de Miguel E, Castillo C, Peiteado D, Martin-Mola E,. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford) 2010; 49: 683-90.
16. Peluso G, Michelutti A, Bosello S, Gremese E, Tolusso B, Ferraccioli G,. Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis 2011; 70: 172-5.
17. Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Wakefield R, et al. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis 2011; 70: 792-8.
18. Saleem B, Brown AJ, Quinn M, Karim Z, Hensor EM, Conaghan P, et al. Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study. Ann Rheum Dis 2012; 71: 1316-21.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
20. Prevoo ML, van Gestel AM, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL,. Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996; 35: 1101-5.
21. Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS,. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005; 52: 2625-36.
22. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32: 2485-7.
23. Naredo E, Moller I, Cruz A, Carmona L, Garrido J,. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008; 58: 2248-56.
24. Naredo E, Rodriguez M, Campos C, Rodriguez-Heredia JM, Medina JA, Giner E, et al, for the Ultrasound Group of the Spanish Society of Rheumatology. Validity, reproducibility, and responsiveness of a twelve-joint simplified power Doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. Arthritis Rheum 2008; 59: 515-22.
25. Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum 2009; 61: 1194-201.
26. Perricone C, Ceccarelli F, Modesti M, Vavala C, Di Franco M, Valesini G, et al. The 6-joint ultrasonographic assessment: a valid, sensitive-to-change and feasible method for evaluating joint inflammation in RA. Rheumatology (Oxford) 2012; 51: 866-73.
27. Schmidt WA,. Value of sonography in diagnosis of rheumatoid arthritis. Lancet 2001; 357: 1056-7.
28. Wakefield RJ, Brown AK, O'Connor PJ, Emery P,. Power Doppler sonography: improving disease activity assessment in inflammatory musculoskeletal disease [editorial]. Arthritis Rheum 2003; 48: 285-8.
29. Wakefield RJ, D'Agostino MA, Naredo E, Buch MH, Iagnocco A, Terslev L, et al. After treat-to-target: can a targeted ultrasound initiative (TUI) improve RA outcomes? Ann Rheum Dis 2012; 71: 799-803.
30. Mandl P, Naredo E, Wakefield RJ, Conaghan PG, D'Agostino MA, for the OMERACT Ultrasound Task Force. A systematic literature review analysis of ultrasound joint count and scoring systems used to assess synovitis in rheumatoid arthritis, according to the OMERACT filter. J Rheumatol 2011; 38: 2055-62.
31. Filer A, de Pablo P, Allen G, Nightingale P, Jordan A, Jobanputra P, et al. Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis 2011; 70: 500-7.